This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Is HealthEquity's Improving Profitability Enough to Offset Key Risks?
by Zacks Equity Research
HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.
UNHPositive Net Change WBSPositive Net Change HQYPositive Net Change
medical medical-devices
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership
by Zacks Equity Research
SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.
ISRGPositive Net Change WSTPositive Net Change GMEDPositive Net Change SENSPositive Net Change
medical medical-devices
Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care
by Zacks Equity Research
HNGE expands HingeSelect to include orthopedic surgery, aiming to deliver coordinated end-to-end MSK care from imaging to post-op recovery.
WSTPositive Net Change GMEDPositive Net Change BDSXPositive Net Change HNGEPositive Net Change
medical medical-devices
Do Options Traders Know Something About AtriCure Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ATRC stock based on the movements in the options market lately.
ATRCPositive Net Change
medical medical-devices
Is PAHC Undervalued at 10x Earnings vs Peers?
by Moumi Mondal
Phibro trades near 10x forward earnings vs higher peer multiples as strong Q3 beat, margin gains and 2026 guidance support a modest upside case.
MRKPositive Net Change ZTSNegative Net Change PAHCNegative Net Change
medical medical-devices
Medtronic Bets on Ablation, Robotics, and Hypertension
by Moumi Mondal
MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.
MDTPositive Net Change SYKPositive Net Change ISRGPositive Net Change
medical medical-devices
TXG Gains From Proteintech Deal, Expands Multiomics Capabilities
by Zacks Equity Research
10x Genomics stock rises after acquiring Proteintech Genomics, adding high-plex proteomics tools that strengthen multiomics research and support platform adoption.
ISRGPositive Net Change WSTPositive Net Change GMEDPositive Net Change TXGPositive Net Change
medical medical-devices
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
by Zacks Equity Research
VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.
ISRGPositive Net Change WSTPositive Net Change GMEDPositive Net Change VEEVPositive Net Change
medical medical-devices
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress
by Debanjana Dey
DVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.
BAXPositive Net Change DVAPositive Net Change RMTIPositive Net Change
medical medical-devices
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
by Zacks Equity Research
NPCE rides strong RNS adoption and AI tools nearing FDA review, with a mid-2026 IGE decision offering upside despite near-term losses.
WSTPositive Net Change PAHCNegative Net Change BDSXPositive Net Change NPCEPositive Net Change
medical medical-devices